RevBio, a biomedical startup and MPWRM Resource Center ITP award recipient, received approval to start a dental clinical trial in Italy for its regenerative biomaterial. The company announced that it has received approval from the Italian Ministry of Health and the Ethics Committee of the University “G.D’Annunzio” of Chieti-Pescara to start a 15-patient pilot clinical trial. Learn more about this new development on the news release.
